570 related articles for article (PubMed ID: 21976403)
21. Toxic effects of chronic low-dose exposure of thioacetamide on rats based on NMR metabolic profiling.
Wei DD; Wang JS; Wang PR; Li MH; Yang MH; Kong LY
J Pharm Biomed Anal; 2014 Sep; 98():334-8. PubMed ID: 24996005
[TBL] [Abstract][Full Text] [Related]
22. The value of decreased plasma gelsolin levels in patients with systemic lupus erythematosus and rheumatoid arthritis in diagnosis and disease activity evaluation.
Hu Y; Li H; Li WH; Meng HX; Fan YZ; Li WJ; Ji YT; Zhao H; Zhang L; Jin XM; Zhang FM
Lupus; 2013 Dec; 22(14):1455-61. PubMed ID: 24122723
[TBL] [Abstract][Full Text] [Related]
23. Comparative analysis of targeted metabolomics: dominance-based rough set approach versus orthogonal partial least square-discriminant analysis.
Blasco H; Błaszczyński J; Billaut JC; Nadal-Desbarats L; Pradat PF; Devos D; Moreau C; Andres CR; Emond P; Corcia P; Słowiński R
J Biomed Inform; 2015 Feb; 53():291-9. PubMed ID: 25499899
[TBL] [Abstract][Full Text] [Related]
24. Increased chromogranin A levels indicate sympathetic hyperactivity in patients with rheumatoid arthritis and systemic lupus erythematosus.
Capellino S; Lowin T; Angele P; Falk W; Grifka J; Straub RH
J Rheumatol; 2008 Jan; 35(1):91-9. PubMed ID: 18061980
[TBL] [Abstract][Full Text] [Related]
25. Health status in systemic lupus erythematosus compared to rheumatoid arthritis and healthy controls.
Gilboe IM; Kvien TK; Husby G
J Rheumatol; 1999 Aug; 26(8):1694-700. PubMed ID: 10451064
[TBL] [Abstract][Full Text] [Related]
26. Application of (1)H NMR-based serum metabolomic studies for monitoring female patients with rheumatoid arthritis.
Zabek A; Swierkot J; Malak A; Zawadzka I; Deja S; Bogunia-Kubik K; Mlynarz P
J Pharm Biomed Anal; 2016 Jan; 117():544-50. PubMed ID: 26476882
[TBL] [Abstract][Full Text] [Related]
27. 1H NMR spectroscopy-based interventional metabolic phenotyping: a cohort study of rheumatoid arthritis patients.
Lauridsen MB; Bliddal H; Christensen R; Danneskiold-Samsøe B; Bennett R; Keun H; Lindon JC; Nicholson JK; Dorff MH; Jaroszewski JW; Hansen SH; Cornett C
J Proteome Res; 2010 Sep; 9(9):4545-53. PubMed ID: 20701312
[TBL] [Abstract][Full Text] [Related]
28. Serum levels of pregnenolone and 17-hydroxypregnenolone in patients with rheumatoid arthritis and systemic lupus erythematosus: relation to other adrenal hormones.
Vogl D; Falk W; Dorner M; Schölmerich J; Straub RH
J Rheumatol; 2003 Feb; 30(2):269-75. PubMed ID: 12563679
[TBL] [Abstract][Full Text] [Related]
29. Possible role of leptin in hypoandrogenicity in patients with systemic lupus erythematosus and rheumatoid arthritis.
Härle P; Pongratz G; Weidler C; Büttner R; Schölmerich J; Straub RH
Ann Rheum Dis; 2004 Jul; 63(7):809-16. PubMed ID: 15194576
[TBL] [Abstract][Full Text] [Related]
30. Metabolic fingerprints of proliferative diabetic retinopathy: an 1H-NMR-based metabonomic approach using vitreous humor.
Barba I; Garcia-Ramírez M; Hernández C; Alonso MA; Masmiquel L; García-Dorado D; Simó R
Invest Ophthalmol Vis Sci; 2010 Sep; 51(9):4416-21. PubMed ID: 20375324
[TBL] [Abstract][Full Text] [Related]
31. NMR-based metabonomic study of the sub-acute toxicity of titanium dioxide nanoparticles in rats after oral administration.
Bu Q; Yan G; Deng P; Peng F; Lin H; Xu Y; Cao Z; Zhou T; Xue A; Wang Y; Cen X; Zhao YL
Nanotechnology; 2010 Mar; 21(12):125105. PubMed ID: 20203358
[TBL] [Abstract][Full Text] [Related]
32. A pilot metabolic profiling study in serum of patients with chronic kidney disease based on (1) H-NMR-spectroscopy.
Qi S; Ouyang X; Wang L; Peng W; Wen J; Dai Y
Clin Transl Sci; 2012 Oct; 5(5):379-85. PubMed ID: 23067349
[TBL] [Abstract][Full Text] [Related]
33. Expression of Fcgamma and complement receptors on peripheral blood monocytes in systemic lupus erythematosus and rheumatoid arthritis.
Hepburn AL; Mason JC; Davies KA
Rheumatology (Oxford); 2004 May; 43(5):547-54. PubMed ID: 14747618
[TBL] [Abstract][Full Text] [Related]
34. Metabonomic analysis of rat urine ¹H magnetic resonance spectra based on different normalization methods.
Mamtimin B; Hasim A; Chen C; Upur H
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2010 Dec; 35(12):1214-8. PubMed ID: 21200086
[TBL] [Abstract][Full Text] [Related]
35. Metabolic signatures of lung cancer in biofluids: NMR-based metabonomics of blood plasma.
Rocha CM; Carrola J; Barros AS; Gil AM; Goodfellow BJ; Carreira IM; Bernardo J; Gomes A; Sousa V; Carvalho L; Duarte IF
J Proteome Res; 2011 Sep; 10(9):4314-24. PubMed ID: 21744875
[TBL] [Abstract][Full Text] [Related]
36. Urine metabolic signature of pancreatic ductal adenocarcinoma by (1)h nuclear magnetic resonance: identification, mapping, and evolution.
Napoli C; Sperandio N; Lawlor RT; Scarpa A; Molinari H; Assfalg M
J Proteome Res; 2012 Feb; 11(2):1274-83. PubMed ID: 22066465
[TBL] [Abstract][Full Text] [Related]
37. A pilot metabolic profiling study in hepatopancreas of Litopenaeus vannamei with white spot syndrome virus based on ¹H NMR spectroscopy.
Liu PF; Liu QH; Wu Y; Jie H
J Invertebr Pathol; 2015 Jan; 124():51-6. PubMed ID: 25450952
[TBL] [Abstract][Full Text] [Related]
38. Quantitative metabolomic profiling of serum and urine in DSS-induced ulcerative colitis of mice by (1)H NMR spectroscopy.
Schicho R; Nazyrova A; Shaykhutdinov R; Duggan G; Vogel HJ; Storr M
J Proteome Res; 2010 Dec; 9(12):6265-73. PubMed ID: 20886908
[TBL] [Abstract][Full Text] [Related]
39. Serum neopterin, tumor necrosis factor-alpha and soluble tumor necrosis factor receptor II (p75) levels and disease activity in Egyptian female patients with systemic lupus erythematosus.
Mahmoud RA; El-Gendi HI; Ahmed HH
Clin Biochem; 2005 Feb; 38(2):134-41. PubMed ID: 15642275
[TBL] [Abstract][Full Text] [Related]
40. Prevalence of anti-3-nitrotyrosine antibodies in the joint synovial fluid of patients with rheumatoid arthritis, osteoarthritis and systemic lupus erythematosus.
Khan F; Siddiqui AA
Clin Chim Acta; 2006 Aug; 370(1-2):100-7. PubMed ID: 16513103
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
